Corbus Pharmaceuticals Holdings (CRBP) Debt Ratio (2013 - 2024)

Corbus Pharmaceuticals Holdings' Debt Ratio history runs 6 years deep, the most recent figure standing at 0.07 for Q2 2024.

• On a quarterly basis, Debt Ratio fell 83.14% year-over-year to 0.07 in Q2 2024; TTM through Jun 2024 was 0.07, a 83.14% decrease from a year earlier, with the FY2023 full-year figure at 1.13, up 297.36% from the prior year.
• Debt Ratio fell to 0.07 in Q2 2024 per CRBP's latest filing, from 0.1 in the prior quarter.
• Across five years, Debt Ratio topped out at 1.13 in Q4 2023 and bottomed at 0.07 in Q2 2024.
• The 5-year median for Debt Ratio is 0.19 (2020), against an average of 0.28.
• Across the five-year window, Debt Ratio jumped 297.36% in 2023 and slumped 83.14% in 2024, its largest moves.
• Year by year, Debt Ratio stood at 0.18 in 2020, then declined by 1.36% to 0.17 in 2021, then soared by 62.9% to 0.28 in 2022, then soared by 297.36% to 1.13 in 2023, then tumbled by 93.72% to 0.07 in 2024.
• Per Business Quant, the three latest CRBP Debt Ratio figures stand at 0.07 (Q2 2024), 0.1 (Q1 2024), and 1.13 (Q4 2023).